Equipoise Laboratory Research Overview
Equipoise (Boldenone Undecylenate) by Odin Pharmaceuticals is a synthetic anabolic-androgenic steroid compound originally developed for veterinary applications. This injectable research chemical features a unique undecylenate ester modification that extends its molecular activity profile in laboratory models. Researchers at Stroid UK Shop can examine this compound’s distinctive structural properties, including its reduced aromatisation characteristics compared to testosterone analogues. The formulation demonstrates moderate anabolic properties with reduced androgenic effects in preclinical tissue studies, making it valuable for comparative steroid receptor research applications.
Molecular Research Applications
Laboratory investigations focus on Equipoise’s interaction with androgen receptors and its metabolic pathways in cellular models. Researchers study its aromatisation resistance properties, examining how the compound’s structural modifications affect enzyme binding affinity. The undecylenate ester chain provides extended release kinetics, allowing scientists to evaluate sustained-release mechanisms in tissue culture systems. Studies investigate its effects on protein synthesis pathways, nitrogen retention in cellular environments, and comparative analysis against other compounds available in our Equipoise research category. Scientists also examine its interaction with cytochrome P450 enzymes and hepatic metabolism patterns in laboratory models.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Boldenone Undecylenate |
| CAS Number | 13103-34-9 |
| Molecular Formula | C₃₀H₄₄O₃ |
| Molecular Weight | 452.67 g/mol |
| Volume | 10ml |
| Manufacturer | Odin Pharmaceuticals |
| Storage | Room temperature, protect from light |
This formulation provides researchers with consistent molecular composition for comparative studies alongside other steroid compounds in our SARMs collection and peptide research range.
Research Compliance Statement
Equipoise by Odin Pharmaceuticals is intended strictly for in-vitro laboratory research purposes only. This compound is not approved for human consumption, therapeutic use, or any applications outside controlled laboratory environments. Researchers must handle this material according to institutional safety protocols and applicable regulations. Purchase is restricted to qualified research institutions and licensed laboratories for legitimate scientific investigations only.
